FDA Considering Presbyopic Implantable Lens

Presbia, a medical device producer of near-vision restoration, reportedly has received a letter from the U.S. Food & Drug Administration (FDA) indicating that it is being actively considered for an Investigational Device Exemption (IDE, G120225) for its Presbia Flexivue Microlens, an implantable corneal inlay solution for presbyopia, the age-related loss of near vision.Read more.